Internal Medicine · St Petersburg, FL
NPI
1588658348
Since 2005
Specialty
Internal Medicine
Code 207R00000X
Group practices
5
Medicare group memberships
Hospitals
6
Hospital affiliations
1839 Central Ave
St Petersburg, FL, 33713
Phone (727) 322-1054
Groups this clinician bills Medicare through
Medicare paid, 2024
$301K
4,719 services
Medicare patients, 2024
880
Average age 73
Drug cost, 2024
$5.4M
57,010 prescriptions
Company payments, 2025
$4,613
From 32 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Fadi Saba was code 99232 (hospital e&m - subsequent), 1,417 times for 284 patients. In total Fadi Saba billed 4,719 services in 69 codes, and Medicare paid $301K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-12-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 1,417 | 284 | $61.14 | $87K |
| 99214 Office E&M - Established | Office | 547 | 177 | $89.80 | $49K |
| 99349 Home E&M - New and Established | Office | 342 | 108 | $94.86 | $32K |
| 36415 Venipuncture Blood Collection | Office | 234 | 135 | $8.61 | $2,016 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 222 | 35 | $45.16 | $10K |
| 99233 Hospital E&M - Subsequent | Facility | 214 | 168 | $91.10 | $19K |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 157 | 32 | $34.39 | $5,399 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 128 | 128 | $125.54 | $16K |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 124 | 124 | $15.87 | $1,967 |
| 99484 Behavioral Health Services | Office | 109 | 21 | $41.11 | $4,481 |
| 99497 Care Management/Coordination | Office | 107 | 106 | $76.17 | $8,150 |
| 99211 Office E&M - Established | Office | 105 | 78 | $15.20 | $1,596 |
| 82962 Clinical Chemistry | Office | 95 | 38 | $3.18 | $302 |
| G0442 Annual alcohol misuse screening, 5 to 15 minutes | Office | 92 | 92 | $15.00 | $1,380 |
| 99223 Hospital E&M - Initial | Facility | 85 | 79 | $133.28 | $11K |
By year: 2022 $569K for 7,380 services; 2023 $399K for 5,630 services; 2024 $301K for 4,719 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 234 | 135 | $8.61 | $2,016 |
| 82962 Clinical Chemistry | 95 | 38 | $3.18 | $302 |
| 81002 Clinical Chemistry | 21 | 19 | $3.09 | $64.79 |
Medicare prescription drug claims, 2024
In 2024, the drug Fadi Saba prescribed most often to Medicare patients was Atorvastatin Calcium, with 2,778 prescriptions and refills. In total Fadi Saba wrote 57,010 Medicare prescriptions that cost $5.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 2,778 | 3,892 | 657 | $39K |
| Eliquis Apixaban | 1,858 | 1,983 | 246 | $707K |
| Levothyroxine Sodium Generic | 1,648 | 2,114 | 300 | $19K |
| Gabapentin Generic | 1,567 | 1,963 | 328 | $35K |
| Amlodipine Besylate Generic | 1,565 | 2,292 | 375 | $13K |
| Lisinopril Generic | 1,379 | 2,008 | 315 | $13K |
| Furosemide Generic | 1,191 | 1,409 | 252 | $7,201 |
| Metformin Hcl Generic | 1,179 | 1,745 | 270 | $11K |
| Metoprolol Tartrate Generic | 1,119 | 1,480 | 251 | $11K |
| Trazodone Hcl Generic | 967 | 1,066 | 219 | $12K |
| Tamsulosin Hcl Generic | 961 | 1,140 | 207 | $17K |
| Losartan Potassium Generic | 939 | 1,508 | 250 | $10K |
| Levetiracetam Generic | 821 | 901 | 126 | $35K |
| Potassium Chloride Generic | 798 | 901 | 168 | $21K |
| Famotidine Generic | 782 | 963 | 175 | $12K |
Brand drugs: 9,699 claims; generic drugs: 47,030 claims; opioid claims: 1,051.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Fadi Saba $4,613 ($4,613 in general payments such as food, travel and fees) from 32 companies. The largest payer was Bayer Healthcare Pharmaceuticals Inc. with $2,957.
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 9 | $2,957 |
| Abbvie Inc. ABBV | 11 | $203 |
| Cipher Pharmaceuticals US LLC CPH.TO | 1 | $195 |
| Pfizer Inc. PFE | 10 | $186 |
| Teva Pharmaceuticals USA, Inc. TEVA | 12 | $142 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 7 | $115 |
| Abbott Laboratories ABT | 3 | $73.65 |
| GlaxoSmithKline, LLC. GSK | 4 | $70.3 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 3 | $67.69 |
| Novo Nordisk Inc NVO | 3 | $62.16 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.